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BnBr (1.54 g, 9.0 mmol) was added in one portion to a solution of compound S2 (1.0 g, 6.0 mmol), K2CO3 (1.66 g, 12.0 mmol) and KI (200 mg, 1.2 mmol) in DMF (20 mL). The reaction mixture was stirred at 90 o C overnight. At this point, TLC (silica, 1:3 EtOAc-hexanes) showed the reaction was complete.
The reaction mixture was cooled to room temperature, and then filtered through a pad of Celite using Ethyl Acetate (50 mL) as the eluent and the filtrate concentrated. The residue was purified by column chromatography (silica, EtOAc-hexanes, 1: 4) gave desired compound (1.4 g, 91%) as a white solid. To a solution of this (1.3 g, 5.1 mmol) in AcOH (20 mL) was added HNO3 (5 mL) at 0 o C. The reaction mixture was stirred at the same temperature for 12 h at which point TLC (silica, 1:3 EtOAc-hexanes)
showed the reaction was complete. The reaction mixture was diluted with Ice-Water (60 mL), and then filtered, washed with Ice-Water (20 mL). The precipitated product was recrystallized from ethanol to yield product (1.1g, 75%) as a yellow solid. The yellow solid (1.1 g, 4.3 mol) was slowly added to TFA (15 mL) at 0 o C for 1 h, and then the result mixture was stirred at room temperature overnight at which point TLC (silica, 1:3 EtOAc-hexanes) showed the reaction was complete. The reaction mixture was diluted with Ice-Water (60 mL), and then filtered, washed with Ice-Water (20 mL). The precipitated product was purified by column chromatography (silica, EtOAc-hexanes, 1:4 → 1:1) gave compound S3 (590 mg, 69%) as a white solid. 1 
Compound S5.
Compound S4 (425 mg, 1.8 mmol) was added in one portion to a solution of compound S3 (250 mg, 
Compound S8.
NaBH4 (54 mg, 1.4 mmol) was slowly added to a solution of compound S5 (500 mg, 1.4 mmol) in THF/MeOH (16mL, 1:1). The reaction mixture was stirred at room temperature 0.5 h. At this point, TLC
(silica, 1:2 EtOAc-hexanes) showed the reaction was complete. The reaction mixture was evaporated, and then diluted with Et2O (20 mL), washed with 1M HCl (10 mL), saturated NaHCO3 (10 mL), and brine (10 mL). The aqueous layer was extracted with Et2O (20 mL). The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography
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(silica, EtOAc-hexanes, 1:4 → 1:1) gave compound S6 (450 mg, 91%) as a yellow oil. A solution of compound S6 (400 mg, 1.1 mmol), Et3N (326 mg, 3.2 mmol) and DMAP (13 mg, 0.1 mmol) in THF (20 mL) was slowly added to Compound S7 (325 mg, 1.6 mmol) in THF. The reaction mixture was stirred at 0 o C 3h. At this point, TLC (silica, 1:3 EtOAc-hexanes) showed the reaction was complete. The reaction mixture was quenched with 5% HCl (20 mL), and the aqueous layer was extracted with Ethyl Acetate (20 mL), washed with saturated NaHCO3 (10 mL), and brine (10 mL). The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (silica, EtOAc-hexanes, 1: 4) gave desired compound S8 (510 mg, 88%) as a yellow oil. 
H NMR (400 MHz
,
Compound S10.
A solution of compound S8 (200 mg, 0.37 mmol), Et3N (101 mg, 1.0 mmol) in THF (6 mL) was slowly added to Compound S9 (107 mg, 0.5 mmol) in THF (0.5 mL). The reaction mixture was stirred at room temperature 0.5 h. At this point, TLC (silica, 1:1 EtOAc-hexanes) showed the reaction was complete. The reaction mixture was quenched with 5% HCl (5 mL), and the aqueous layer was extracted with Ethyl Acetate (20 mL), washed with saturated NaHCO3 (10 mL), and brine (10 mL). The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (silica, EtOAc-hexanes, 2: 1) gave desired compound S10 (220 mg, 96%) as a yellow oil. 1 Compound S11.
2M HCl (3 mL) was slowly added to a solution of compound S10 (200 mg, 0.33 mmol) in THF (6mL).
The reaction mixture was stirred at room temperature 0.5 h. At this point, TLC (silica, 3:1 EtOAchexanes) showed the reaction was complete. The reaction mixture was quenched with saturated NaHCO3 (10 mL), and the aqueous layer was extracted with Ethyl Acetate (20 mL), washed with brine (10 mL).
The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (silica, EtOAc) gave desired compound S11 (152 mg, 92%) as a yellow oil. 1 
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Compound S12.
A solution of compound S11 (140 mg, 0.28 mmol), Et3N (85 mg, 0.84 mmol) and DMAP (4 mg, 0.03 mmol) in THF (10 mL) was slowly added to Compound S7 (85 mg, 0.42 mmol) in THF (5 mL). The reaction mixture was stirred at 0 o C 3 h. At this point, TLC (silica, 2:1 EtOAc-hexanes) showed the reaction was complete. The reaction mixture was quenched with 5% HCl (10 mL), and the aqueous layer was extracted with Ethyl Acetate (20 mL), washed with saturated NaHCO3 (10 mL), and brine (10 mL).
The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (silica, EtOAc-hexanes, 1: 1) gave desired compound S12 (150 mg, 81%) as a yellow oil. 1 
Compound 6.
A solution of compound S12 (100 mg, 0.15 mmol), Et3N (37 mg, 0.36 mmol) in THF (6 mL) was slowly added to Compound S13 (75 mg, 0.18 mmol) in THF (0.5 mL). The reaction mixture was stirred at room temperature 0.5 h. At this point, TLC (silica, 5:1 EtOAc-MeOH) showed the reaction was complete. The reaction mixture was quenched with 5% HCl (5 mL), and the aqueous layer was extracted with Ethyl Acetate (30 mL), washed with saturated NaHCO3 (10 mL), and brine (10 mL). The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (silica, EtOAc-MeOH, 10: 1) gave desired compound 6 (58 mg, 41%) as a yellow oil. 1 showed it was complete. The reaction mixture was diluted with Et2O (40 mL), washed with 1M HCl (20 mL), saturated NaHCO3 (20 mL), brine (20 mL). The aqueous layer was extracted with Et2O (40 mL).
The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. 
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Compound S21.
A solution of compound S8 (200 mg, 0.37 mmol), Et3N (101 mg, 1.0 mmol) in THF (6 mL) was slowly added to Compound S1 (107 mg, 0.5 mmol) in THF (0.5 mL). The reaction mixture was stirred at room temperature 0.5 h. At this point, TLC (silica, 1:1 EtOAc-hexanes) showed the reaction was complete. The reaction mixture was quenched with 5% HCl (5 mL), and the aqueous layer was extracted with Ethyl Acetate (20 mL), washed with saturated NaHCO3 (10 mL), and brine (10 mL). The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (silica, EtOAc-hexanes, 2:1) gave desired compound S20 (220 mg, 96%) as a yellow oil. 2M HCl (3 mL) was slowly added to a solution of compound S20 (200 mg, 0.33 mmol) in THF (6mL). The reaction mixture was stirred at room temperature 0.5 h. At this point, TLC (silica, 3:1 EtOAc-hexanes) showed the reaction was complete. The reaction mixture was quenched with saturated NaHCO3 (10 mL), and the aqueous layer was extracted with Ethyl Acetate (20 mL), washed with brine (10 mL). The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. 
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reaction was complete. The reaction mixture was quenched with 5% HCl (10 mL), and the aqueous layer was extracted with Ethyl Acetate (20 mL), washed with saturated NaHCO3 (10 mL), and brine (10 mL).
Compound S24.
A solution of compound S22 (100 mg, 0.15 mmol), Et3N (37 mg, 36 mmol) in THF (6 mL) was slowly 
Compound 9.
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Compound 8 (21.5 mg, 0.0242 mmol) and azide S22 (13.7 mg, 0.0145 mmol) were dissolved in a mixture of CH2Cl2/t-BuOH (3:2, w/w, 2 mL). To the mixture were added an aqueous solution of CuSO4
( 
BIOLOGY.
General Methods
All reagents were purchased from commercial sources listed below and were used without further HepG2 cells were cultured in DMEM supplemented with 10% fetal bovine serum and 2 mM Lglutamine at 37°C under 5% CO2.
MTT Cytotoxicity Assay
Viable cells were counted with a hemocytometer immediately before each experiment. Experiments were done in triplicate. First, 100 μL of MCF7 cells at the density of 50,000 cells/mL were seeded in a 96-well plate (5,000 cells/well), which was incubated at 37 º C and 5% CO2 atmosphere for 24 h. The compounds were dissolved in DMSO (dimethyl sulfoxide) to make drug stocks (10 mM). The stock solutions were diluted with the complete DMEM high glucose culture medium to make a series of gradient fresh working solutions right before each test. Subsequently, the cells were treated with 100 μL of the freshly made gradient working solution in a total volume of 200 μL/well for 72 h. After that, the media were discarded and 200 μL of the fresh complete medium containing 10% of MTT stock solution (5 mg/mL) was added to each well. The plate was then incubated at 37 º C and 5% CO2 for 3 h. Next, 180 μL of the medium was discarded from each well, and 180 μL of DMSO was added to each well to dissolve formazan crystals. Absorbance of formazan was detected by a microplate reader (BioTek Synergy H1)
at 570 nm with 650 nm as the reference wavelength. The percentage of viability compared to the negative control (DMSO-treated cells) was determined. GraphPad Prism 6 software was used to make a plot of % viability versus sample concentration and to calculate the concentration at which a compound exhibited 50% cytotoxicity (IC50).
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AlamarBlue Cytotoxicity Assay was determined. GraphPad Prism 6 software was used to make a plot of % viability versus sample concentration and to calculate the concentration at which a compound exhibited 50% cytotoxicity (IC50).
HCT116 and HEK293T
. Viable cells were counted using an automated cell counter (BioRad TC20) before each experiment. Experiments were performed either in quadruplicate or duplicate sets. First 100µl of HCT116 or HEK293T cells at a density of 25,000 cells/ml was seeded in black wall, clear bottom, 96-well plates (2500 cells/well) (Viewplate-96 Perkin Elmer). HEK293 FRT Trex cells were seeded in complete medium supplemented to 1 μg/ml Doxycycline to induce expression of Sec61a constructs. Cells were then incubated at 37 º C and 5% CO2 for 24 h. The compounds were dissolved in DMSO to make drug stocks (10 mM). The stock solutions were diluted with the complete DMEM or McCoy's 5A culture media supplemented with DMSO to make a series of gradient fresh working solutions at equal DMSO percentage immediately prior to each test. Subsequently, the cells were treated with 25 μl of the freshly made gradient in a total volume of 125 μl/well for 72 h. After that, the media were supplemented with 10% of AlamarBlue (resazurin) stock solution. The plate was then incubated at 37 º C and 5% CO2 for another 4 h. Emission of each well at 620 nm was detected by a microplate reader (Perkin Elmer EnSpire)
at excitation 580 nm. The percentage of viability compared to the negative control (DMSO-treated cells) was determined. GraphPad Prism 7 software was used to make a plot of % viability versus sample concentration and to calculate the concentration at which a compound exhibited 50% cytotoxicity (IC50).
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Activity Based Protein Profiling
MDA-MB-231 cells were seeded in five groups of 6 cm petri dishes with 3 ml DMEM high glucose culture and incubated at 37 º C and 5% CO2 until 90% confluency. Each group was treated with fresh medium containing 20 µM competitor or an equal volume of DMSO vehicle for 30 min at 37 º C and 5% CO2, followed by addition of 0.2 µM probe or an equal volume of DMSO. After 1 h incubation at 37 º C and 5% CO2, the cells were harvested by scraping and washed with cold PBS for 3 times. The cells were then lysed in 100 µl of lysis buffer 1 (50 mM Hepes, pH 9.0, 100 mM NaCl, 10% glycerol, 5 mM MgCl2, 1 mM CaCl2, 0.2% NP40, 1x protease inhibitor) using ultrasound sonication. The supernatant of each group was collected after centrifugation at 21,100 g and 4 º C for 10 min, and the protein concentration was quantified with a BCA kit. 10% SDS was then added into protein solution to make a final SDS concentration of 0.4%, and the solution was incubated at 95 º C for 5 min. 1 µl TCEP (100 mM stock solution in H2O) was mixed with 1 µl TBTA (10 mM stock solution in a 4:1 ratio of t-butanol and DMSO), 1 µl CuSO4 (100 mM stock solution in H2O), and 1 µl rhodamine-azide (1 mM stock solution in DMSO).
The mixed solution was added into the previously prepared protein solution containing 0.25 mg protein.
The total volume was adjusted to 100 µl with the lysis buffer 1 to make a final protein concentration of 2.5 mg/ml, and the click reaction was performed at room temperature for 1.5 h. Proteins in 15 µl of the reactant were fractionated by an SDS-PAGE gel. The protein gel was scanned with a typhoon scanner (Typhoon™ FLA 9500) at 532 nm excitation with 700 mV gain setting and then stained with Coomassie blue.
Biotin Affinity Pulldown
Live Cell-based Pulldown
According to the experimental needs, MDA-MB-231 cells were seeded into 3-7 groups of 15-cm tissueculture dishes and incubated at 37 º C and 5% CO2 until 90% confluency. Each group was treated with fresh medium containing a competitor or an equal volume of DMSO vehicle for 30 min at 37 º C and 5% CO2, followed by addition of a probe or an equal volume of DMSO. After 1 h incubation at 37 º C and 5%
CO2, the cells were harvested by scraping and washed with cold PBS for 3 times and lysed with the lysis buffer 2 (50 mM Tris, pH 7.4, 150 mM NaCl, 1% NP40, 0.25% sodium deoxycholate, 10 mM NaF, 10 mM β-glycerophosphate, and 1 mM Na3VO4). The supernatant of each group was collected after centrifugation at 4 º C and 21,100 g for 10 min, and the protein concentration was quantified with the BCA kit. After adjusting protein concentration with lysis buffer 2, each protein solution with equal amount of total protein in the same volume was incubated with 20 µl of washed streptavidin bead at 4 º C for 2 h with S21 rotation. After incubation, the beads were washed with washing buffer (50 mM Tris, pH 7.4, 150mM
NaCl, 1% NP40, 0.25% sodium deoxycholate, 10 mM NaF, 10 mM β-glycerophosphate, and 1 mM Na3VO4) for 3 times and boiled at 95º C for 5 min in 2x sample buffer (125 mM Tris-HCl, pH 6.8, 20%
glycerol, 2% SDS, 2% β-mercaptoethanol and 0.02% bromophenol blue). After centrifugation at 21,100 g and 4 º C for 1 min, the cleared eluted proteins were divided into two parts. beads was added to each sample followed by 2 h incubation at 4 º C with rotation. After washing with washing buffer (50 mM Tris, pH 7.4, and 150 mM NaCl) for 3 times, the bound proteins were eluted by boiling the beads in 20 µl of 2x sample buffer at 95 ºC for 5 min. The eluted proteins were analyzed by SDS-PAGE or Western blotting as described above.
Delayed/Reverse Competition in Live Cell-based Pulldown
The procedure is almost identical to that of the regular pulldown except for the switched order of addition for the biotin probe and ipomoeassin F.
Mass Spectrometry (MS) Analysis and MS Data Processing
In the pulldown, the bound proteins were eluted via boiling the high capacity streptavidin agarose beads in 1x sample buffer. The eluted proteins were fractionated with a 12% SDS-PAGE and the fractionated proteins were visualized by blue silver staining. 8 The ~40 kDa protein band from the probe 7-enriched sample and the corresponding regions of the gel for the negative control and the ipomoeassin F competition sample were cut, in-gel digested, the resulting peptides were analyzed by an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific), and the MS/MS spectra were searched against a composite target-decoy UniProtkB human protein database (2018_02, 20317 entries) using Mascot (Matrix Science, London, UK; version 2.5.1) as described previously. [9] [10] The parameters for database searching were as follows: MS tolerance of 3.0 ppm and MS/MS tolerance of 0.5 Da; tryptic enzyme specificity with a maximum of 2 missed cleavages; fixed modification, carbamidomethyl of cysteine; and variable modifications, oxidation of methionine and acetylation of the N-terminus. Search results were further processed by Scaffold software (version 4.8.6; Proteome Software, Portland, OR) for viewing protein and peptide identification information. In the Scaffold analysis, peptide identifications were accepted if they could achieve a false discovery rate (FDR) of <1.0% by the Scaffold Local FDR algorithm. Protein identifications were accepted if they could achieve an FDR of <1.0% and contained at least 2 identified peptides. Total spectral counts were exported from Scaffold and used to represent relative protein abundance from different samples based on the positive, linear correlation between spectral count and the abundance of a protein in complex samples. [11] [12] [13] Contaminant proteins such as keratins were discarded.
For reliable representation of protein abundance, proteins identified with <4 spectra in the probe 7-enriched sample were discarded.
12
Cell Imaging
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MDA-MB-231 cells were seeded on fibronectin-coated coverslips at 70% confluency in a 48-well plate and cultured at 37 º C and 5% CO2. After 24 h, culture medium was replaced with fresh medium containing a 20 µM competitor or an equal volume of DMSO vehicle for 30 min at 37 º C and 5% CO2, followed by addition of 0.2 µM (final concentration) fluorescent probe 12. After 1 h incubation at 37 º C and 5% CO2, the coverslips were mounted onto a glass slide with a mounting medium with or without 0.5 µg/ml DAPI.
The fluorescent images were acquired with a confocal microscope (Leica TCS SP5) using 405 nm excitation and 562 nm excitation. For the ER co-localization studies, 1 uM ER-Tracker™ Blue-White DPX was added to the medium after 1 h incubation with probe 12. After 5 min incubation, the coverslips were mounted onto a glass slide and the images were acquired as described above.
Photo-Affinity Labeling.
CT7 photo-affinity labeling and click chemistry were done as previously described. 14 Briefly, SRMs (sheep rough microsomes, isolated as described in reference 15 ) containing 100 nM Sec61 were treated with 10 µM ipomoeassin F/mycolactone or 1% DMSO for 30 min at 0°C, followed by incubation with 100 nM CT7 for 10 min RT. Samples were then photolyzed for 10 min and crosslinked proteins were detected by click chemistry, SDS-PAGE, and in-gel fluorescent scanning (Typhoon Trio, GE Healthcare).
In Vitro Membrane Translocation Assays.
DNA constructs
Unless otherwise stated, all cDNAs are of human origin and as previously described: CytB5OPG2, 16 GypC, 17 17 Ii encodes residues 17 to 232 of the short form of human HLA class II histocompatibility antigen gamma chain (Ii; P04232, isoform 2). Linear DNA templates were generated by PCR and transcribed into RNA using T7 or SP6 polymerase (Promega).
In vitro translation and translocation into ER microsomes
Translation reactions ( V, 120 min), gels were fixed (20% MeOH, 10% AcOH) for 5 min, dried (BioRad gel dryer) for 2 h at 65°C and, following exposure to a phosphorimaging plate for 24-72 h, radiolabelled products were visualised using a Typhoon FLA-7000 (GE Healthcare).
Statistical Analysis
Quantitative analysis of Ii membrane insertion was performed using AIDA v.5.0 (Raytest Isotopenmeβgeräte) whereby the ratio of the signal intensity for the 2Gly/0Gly forms was used as a readout to estimate efficiency of integration into the ER membrane. This value was then expressed relative to the matched DMSO control in order to derive the mean relative ER insertion from three independent experiments (n=3). Statistical significance of the effectiveness of Ipom-F analogues (RM one-way ANOVA) was determined using Tukey's multiple comparisons test. IC50 value estimates were determined using non-linear regression to fit data to a curve of variable slope (four parameters) using the least squares fitting method in which the bottom and top plateaus of the curve were defined as 0% and 100%
respectively. The differences between the estimated IC50 values for the three compounds analysed were statistically significant (****) according to the extra-sum-of-squares F test. Statistical analyses and IC50
estimates were performed using Prism 7.0d (GraphPad) with statistical significance given as n.s., nonsignificant and ****, P < 0.0001.
U2-OS secNLuc-ATZ Secretion and Cell Viability Assays
The secNLuc-ATZ assay has been described elsewhere. 18 Briefly, U2-OS cells stably expressing secNLuc-ATZ were cultured in McCoy's 5A supplemented with 10% bovine growth serum (Hyclone SH30540.03), 50 units/mL penicillin, and 50 µg/mL streptomycin and plated into 1536-well black, clearbottom treatment plates (Aurora Microplates #ABI121000A) at 1200 cells/well in 5 µL volume using a Multidrop Combi dispenser (ThermoFisher). Cells were returned to 37 ˚C for 1 h to adhere and compound or vehicle control was added to wells using a 1536-well pin-tool transfer device (Wako Automation, San Diego). Cells were incubated for 24 h and secNLuc-ATZ-containing media was transferred using an ATS-100 acoustic dispenser (EDC Biosystems, Fremont, CA) from the treatment plate to a white, solidbottom 1536-well recipient plate (Greiner Bio One #789175-F) containing 3 µL/well of 1X PBS. Next, recipient plates received 2 µL/well Nano-Glo luciferase assay reagent by BioRAPTR FRD (Beckman Coulter), incubated for 10 min then imaged on a ViewLux uHTS Microplate Imager (PerkinElmer).
For the multiplexed cytotoxicity assay (24 h), after acoustic media transfer 3 µL/well CellTiter-Glo reagent (Promega) was added by BioRAPTR FRD to the black, clear-bottom treatment plate containing treated cells, incubated for 10 min, and then imaged with a ViewLux. Imaging conditions for the multiplexed cytotoxicity assay were: clear filter with 10 sec integration, slow speed, high sensitivity, and 2X binning.
SH-SY5Y GLuc Secretion and Cell Viability Assays.
SH-SY5Y human neuroblastoma cells stably expressing a constitutively secreted variant of Gaussia luciferase (GLuc-'No Tag') were previously described. 19 Cells were cultured in DMEM (4.5 g/L Dglucose, 1 mM sodium pyruvate) supplemented with 10% bovine growth serum (Hyclone SH30540.03) 20 mM Hepes, 50 units/mL penicillin, and 50 µg/mL streptomycin. Cells were plated into white 1536-well tissue culture treated plates (Corning cat. #7464) at 1,000 cells per well in a 5 µL volume using a Multidrop Combi dispenser. Cells were returned to 37 ˚C for 4 h to adhere and compound or vehicle control was added to wells using a 1536-well pin-tool transfer device (Wako Automation, San Diego).
Cells were incubated at 37 ˚C for 24 h and secreted luciferase was detected by adding 1 µL of coelenterazine substrate to each well using a BioRAPTR FRD workstation. The substrate was prepared from a Pierce Gaussia Luciferase Glow Assay Kit (ThermoFisher) by adding 1 volume of coelenterazine to 99 volumes of Gaussia Glow Assay Buffer (final concentration of coelenterazine = 0.17X).
Luminescence was measured using a ViewLux microplate imager equipped with clear filters.
For cell viability assays, cells were cultured, plated, and treated with test compounds as outlined for the secretion assays. 48 h after treatment, viability was assessed using a CellTiter-Glo assay by adding 3
S26
µL of reagent to each well, incubating 15 min at room temperature, and reading luminescence using a ViewLux microplate imager.
Metabolic Labelling Assays in HCT116 Cells
HCT116 cells were counted using an automated cell counter (BioRad TC20) immediately prior to each experiment. 3 ml of HCT116 cells at a density of 0.166x10 6 cells/mL were seeded to 6-well plates (0.5x10 6 cells/well) and then incubated at 37 º C and 5% CO2 for 24 h. The compounds were dissolved in DMSO to make drug stocks (10 mM). The stock solutions were diluted with DMEM high glucose culture medium lacking methionine and cysteine to make a fresh working solution immediately prior to each test. Cells were washed twice and 1ml of fresh DMEM lacking methionine and cysteine was added to each well.
Subsequently, the cells were treated with 250 µl of compound solutions in a total volume of 1,250 µl/well.
The plate was then incubated at 37 º C and 5% CO2 for 30 min before 100 µCi 
Pulse-Chase Analysis of Protein Secretion in HepG2 Cells
The secretion assay was performed using a pulse-chase approach as described previously. 20 HepG2 cells were treated with DMSO, 100 nM compound 8, 100 nM Ipom-F or 31.3 ng/μl mycolactone for 13.5 h before initiating the experiment, whereas pre-treatment with bortezomib 100 nM (Stratech) or 2.5 μg/ml brefeldin A were performed for 2 h and 1 h, respectively. Cells were starved in Met-and Cys-free DMEM 
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of precipitated proteins in the media and clarified lysates were analyzed by SDS-PAGE and phosphorimaging (FLA-3000; Fuji).
T Cell Assays
Jurkat E6.1 (ATCC TIB-152TM) T cells were cultured in RPMI GlutamaxTM (Life Technologies), supplemented with 10% heat-inactivated fetal calf serum (FCS) (Invitrogen) and penicillin/streptomycin (100 U/ml, 100 µg/ml). Cells were treated with Ipomoeassin F or mycolactone for 24 h, then pelleted and stained with FITC-conjugated anti-human CD62L (clone DREG-56 (BioLegend #304804) at 500 ng/ml) during 40 min at 4°C. Fluorescence signals were acquired on an Accuri CD (BD) and analyzed with the FlowJo X software. Immunosuppressive activity on T cells was measured through the inhibition of IL-2 production by Jurkat T cells incubated with mycolactone for 1 h prior to 24 h of activation with phytohemagglutinin-ionomycin, as described. 21 In both assays, blanks corresponded to cells treated with the vehicle volume of the highest concentration of sample tested (DMSO for IpoF; EtOH for mycolactone).
Washout assay
The reversibility of the inhibition of secreted protein production by ipomoeassin F was determined by following the production of TNF in RAW264.7 cells as described before. 22 Briefly, RAW264.7 cells were maintained at 37 ⁰C and 5% CO2 in high glucose DMEM (Merck), supplemented with 10% heatinactivated FBS (GIBCO). Cells were plated into 24 well plates at a concentration of 1 x 10 5 /ml 24 hour prior to assay, then incubated for 1 hour in the presence or absence of 125 ng/ml mycolactone, 250 nM Ipomoeassin F or DMSO carrier. Cells were either stimulated directly with 100 ng/ml TLR-grade LPS (Enzo) or washed 3 times with medium and incubated 24 hour, then stimulated with LPS. In each case, cells were incubated with LPS for 4 hour then the supernatants were removed. The concentration of TNF in supernatants was quantified by ELISA (eBioscience).
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Figures:
Cell Cytotoxicity Assay A.
B.
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C. 
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In Vitro Membrane Insertion Assays of a Model Type II Protein. Each phosphorimage depicts experiments performed using a translation master mix, to which different compounds and Ii mRNA were then added prior to translation and analysis of the membrane-associated fraction from three independent experiments (n=3). 
Pulse-Chase Analysis of Protein Secretion in HepG2 Cells
